The development of a 'best practice' service for women in a medium-secure psychiatric setting: treatment components and evaluation

Clinical Psychology & Psychotherapy
C G LongC R Hollin

Abstract

The inadequacy of inpatient facilities for women with severe psychiatric and co-morbid difficulties has been repeatedly documented. The establishment of effective therapeutic programmes for women in medium psychiatric facilities is also in their infancy, and little research has been undertaken. This article describes the development of a 'best practice' psychological treatment programme for women with a dual diagnosis. Emphasis is placed on the need to develop further intensive gender-specific services using an established model for effective therapeutic service development. In addition to a detailed description of the group therapy programme, staff training initiatives, methods for ensuring treatment integrity and a methodology for service evaluation is given.

References

Jan 1, 1989·The Journal of Nervous and Mental Disease·J P McEvoyL Roth
Apr 1, 1980·Archives of General Psychiatry·R S CarrollG M Simpson
Jan 1, 1982·Journal of Applied Behavior Analysis·L PetersonS A Wonderlich
Jan 1, 1994·Acta Psychiatrica Scandinavica·M BirchwoodM Slade
Sep 1, 1994·Social Psychiatry and Psychiatric Epidemiology·M Ruggeri
Dec 1, 1993·The Japanese Journal of Psychiatry and Neurology·Y Koga
Dec 1, 1993·Archives of General Psychiatry·M M LinehanH E Armstrong
Sep 1, 1993·Journal of Advanced Nursing·M Nolan, G Grant
Dec 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·P E MullenG P Herbison
Feb 1, 1996·The British Journal of Clinical Psychology·M BarkhamM Startup
Jan 1, 1996·Schizophrenia Bulletin·M D BellR M Milstein
May 1, 1996·The British Journal of Clinical Psychology·T Cassidy, C Long
Nov 1, 1995·Journal of Clinical Psychology·J H PattonE S Barratt
Aug 6, 1992·Quality in Health Care : QHC·R J Maxwell
Apr 11, 1982·Health Policy and Education·T S Epstein
Sep 17, 1999·Journal of Behavior Therapy and Experimental Psychiatry·D L MilneK Reichelt
Jan 5, 2001·The British Journal of Medical Psychology·J Birtchnell, J Shine
Jul 27, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·V I LushchakK B Storey
Jan 5, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Chris EvansKerry Audin
Apr 11, 2002·Women & Health·Joanna BallUNKNOWN Family Health Project Research Group
Jun 18, 2002·BMJ : British Medical Journal·F DabisUNKNOWN Working Group on Women and Child Health
Nov 7, 2003·Nursing Management·Annette Duff
Nov 25, 2003·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Alan E Kazdin, Matthew K Nock
Jan 16, 2004·Journal of Psychiatric and Mental Health Nursing·J ToddS Sherwood
Jan 24, 2004·Society & Animals : Social Scientific Studies of the Human Experience of Other Animals·Katherine Perlo
Apr 6, 2004·Journal of Substance Abuse Treatment·Christine Timko, Jill M Sempel
Jun 10, 2004·The American Journal of Bioethics : AJOB·Jeremy Sugarman
Sep 15, 2004·Health Policy·Alaka Singh, Barbara Stilwell
Aug 10, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Alexander S YoungJim Mintz
Nov 24, 2005·Medicine, Science, and the Law·Stuart D M ThomasMorven Leese
Dec 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Gillian MezeyAnnie Bartlett
Jan 27, 2006·The American Psychologist·Alan E Kazdin

❮ Previous
Next ❯

Citations

Dec 1, 2010·Behavioural and Cognitive Psychotherapy·Clive G LongClive R Hollin
Feb 22, 2012·Journal of Psychiatric and Mental Health Nursing·C G Long, O Dolley
Jun 1, 2011·Psychology and Psychotherapy·Eimear M CunninghamShirley A Radford
May 5, 2011·Journal of Psychiatric and Mental Health Nursing·C G LongC R Hollin
Mar 10, 2015·International Journal of Law and Psychiatry·Rafael Bernardon RibeiroMaria Fotiadou
Oct 19, 2016·BJPsych Bulletin·Michaela ArcherFaisil Sethi
Oct 25, 2011·Medicine, Science, and the Law·C G LongC R Hollin
Jul 11, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Sue M PenckoferPatrick Lustman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.